No photo of Xu Luo

View Scopus Profile

Xu Luo, PhD

  • 8495 Citations
  • 24 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Xu Luo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Mechanism of Bax/Bak Activation During Apoptosis

Luo, X.

Project: Research project

Bax/Bak activation without direct activator BH3-only proteins in cancer cells

Luo, X.

Project: Research project

Mechanisms of Bax Activation

Luo, X.

National Institutes of Health

2/1/06 → 1/31/12

Project: Research project

    • Nebraska Center for Cellular Signaling

    Johnson, K. R., Simpson, M. A., Wahl, J. K., Caplan, S. H., Nawshad, A., Luo, X., Oakley, G. G., Furukawa, M., Wang, J., Lewis, R. E., Caplan, S. H., Naslavsky, N., Dong, J., Opavsky, R., Wahl, J. K., Solheim, J. C., Peng, A., Luo, X., Simpson, M. A., Wheelock, M., Koka, S., Dey, B., Hansen, L., Gladyshev, V. N., Nawaz, Z., Yaping, T., Wang, Z., Premaraj, S., Taylor, G. S., Tsai, M. & Mehta, P. P.

    National Institutes of Health

    9/19/03 → 6/30/13

    Project: Research project

    • Research Output

    • 8495 Citations
    • 24 h-Index
    • 37 Article
    • 2 Review article

    BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis

    Lee, Y. S., Kalimuthu, K., Park, Y. S., Luo, X., Choudry, M. H. A., Bartlett, D. L. & Lee, Y. J., Oct 1 2020, In : Apoptosis. 25, 9-10, p. 625-631 7 p.

    Research output: Contribution to journal › Article

    • MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment

    Haschka, M. D., Karbon, G., Soratroi, C., O’Neill, K. L., Luo, X. & Villunger, A., Aug 1 2020, In : Cell Death and Differentiation. 27, 8, p. 2297-2312 16 p.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    The third model of Bax/Bak activation: A Bcl-2 family feud finally resolved?

    Luo, X., O'Neill, K. L. & Huang, K., 2020, In : F1000Research. 9, 935.

    Research output: Contribution to journal › Review article

    Open Access

    • Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition

    Roca-Portoles, A., Rodriguez-Blanco, G., Sumpton, D., Cloix, C., Mullin, M., Mackay, G. M., O’Neill, K., Lemgruber, L., Luo, X. & Tait, S. W. G., Aug 1 2020, In : Cell Death and Disease. 11, 8, 616.

    Research output: Contribution to journal › Article

    Open Access

    • BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-XL

    Greaves, G., Milani, M., Butterworth, M., Carter, R. J., Byrne, D. P., Eyers, P. A., Luo, X., Cohen, G. M. & Varadarajan, S., Jun 1 2019, In : Cell Death and Differentiation. 26, 6, p. 1037-1047 11 p.

    Research output: Contribution to journal › Article

    • 19 Scopus citations